iShares Nasdaq Biotechnology (IBB) option IV at low end of range

iShares Nasdaq Biotechnology (NASDAQ: IBB) 30-day option implied volatility is at 14; compared to its 52-week range of 14 to 35 after President Biden unveils first 10 drugs subject to Medicare price negotiation.

You May Also Be Interested In

• Vail Resorts (MTN) call put ratio 1 call to 1 put amid price movement
• Lineage (LINE) call put ratio 1.3 calls to 1 put
• Lincoln National (LNC) call put ratio 11.9 calls to 1 put with a focus on July 40 calls